Hyperthyroidism as a latent complication of autologous hematopoietic stem cell transplantation.
Thyroid dysfunction after hematopoietic stem cell transplantation has been investigated in many studies. Most post-transplant thyroid disorders such as hypothyroidism are recognized as a late complication whilst hyperthyroidism is infrequent and transient, and usually happens early at the onset after transplant. Here, we report two rare hyperthyroid cases, developing more than 2 years after autologous stem cell transplant. We suggest that hyperthyroidism be alerted in the post-transplant care, and special attention be paid to any latent events.
Feng
Yin-Hsun
YH
Department of Hematology and Oncology, Chi Mei Medical Center, Liou Ying Campus, Tainan, Taiwan.
Su
Bo-An
BA
Department of Internal Medicine, Chi Mei Medical Center, Yung-Kang Campus, Tainan, Taiwan.
Lin
Cheng-Yao
CY
Department of Hematology and Oncology, Chi Mei Medical Center, Liou Ying Campus, Tainan, Taiwan.
Huang
Wen-Tsung
WT
Department of Hematology and Oncology, Chi Mei Medical Center, Liou Ying Campus, Tainan, Taiwan.
Tsao
Chao-Jung
CJ
Department of Hematology and Oncology, Chi Mei Medical Center, Liou Ying Campus, Tainan, Taiwan. cjt@mail.chimei.org.tw.
D000328:Adult; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D006980:Hyperthyroidism / Q000209:etiology*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D013997:Time Factors; D014182:Transplantation, Autologous